March 7, 2022

Monday, March 7, 2022: Life Sciences

Jordana Choucair

Jordana Choucair

  • The FDA is getting closer to authorizing Novavax Inc.’s COVID-19 vaccine after the company said it fixed production issues that delayed its application. However, U.S. clearance for the protein-based shot is still a ways off given the FDA must review a lot of data from several countries. Regulators in other countries have authorized Novavax’s vaccine. Health experts hope that offering a protein-based vaccine will help convince those who are wary of mRNA shots to get vaccinated. (Article here)
Jordana is the chief operating officer. In this role, she supports the firm’s daily operations, including financial management, business administration, communications, and human resources. She collaborates closely with the CEO and managing partners to design and implement policies and practices to help the firm shape a future system that actualizes a sustainable culture of health nationwide.